PT Mersifarma TM, named “Mersi” for short, were established in 1997. The founders came from 4 different fields of expertise. These were health, pharmacy, business, and socio-economics. With their pioneering vision and professional expertise, Mersi was founded.
The company was constituted from a strong desire to endeavour in medicines. Which they now undertake by manufacturing medicines needed for large segments of the population.
Mersi initially focused on manufacturing medicines to combat Neuro-Psychiatric, Psychosomatic and Mental Health Diseases. However, need for a much larger extension and augmentation became apparent.
Today other important areas of healthcare are also catered for. They include:
Ear-Nose and Throat Diseases
Advanced antibiotic therapeutic agents
Dedicated to the highest level of scientific excellence, Mersifarma maintain stringent product quality checks. As well as being committed to the highest standard of ethics and integrity.
All products are upheld by strict professional standards. Hence resulting in their impeccable reputation for being known to quality as : Membuat obat Ekivalen Riset Standar Internasional (in Bahasa, Indonesia) or Manufacturing of drugs Equivalent to International Standard Research.
Mersi’s Pharmaceutical factory sits on 78.000 sqm at Cikembar, Sukabumi in West Java, occupying buildings of approximately 13.652 sqm.
The Government of Indonesia’s Ministry of Health through the (formerly) Drug and Food Directorate General of Drug and Food Control granted the Pharmaceutical Operating Permit to Mersi on November 26th, 1998.
Mersi is also an accredited holder of Good Manufacturing Practice (GMP) Certificate and is permitted to produce 17 product items.
In 2005, Mersi produced 75 pharmaceutical products and the company also projected to expand and increase production. This was to keep in line with the aim of the Indonesian Government to achieve Indonesia Sehat 2010 or (Health For Indonesia by 2010).
As a young dynamic pharmaceutical company, Mersi enjoys a sound global reputation. This reputation is solidified as their range of high quality products are distributed in many countries. Like Cambodia, Timor Leste, and Middle Estern countries such as The Republik of Yemen. Through strategic business development, global expansion will continue to thrive in the coming years with exports made accessible to more countries worldwide.
In the coming year, Mersi plans to improve its level of product development by acquiring the latest manufacturing machinery. As well as increase its market presence through active participation in medical and pharmaceutical events both domestically and abroad.